| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8% | $14,020,746 | 1,854,596 | TANG CAPITAL MANAGEMENT, LLC | 31 Mar 2025 | |||
| WASATCH ADVISORS LP | 6.7% | +26% | $7,972,248 | +$1,532,476 | 1,152,059 | +24% | WASATCH ADVISORS LP | 30 Jun 2025 |
As of 31 Dec 2025, 76 institutional investors reported holding 11,022,797 shares of Journey Medical Corp - Common Stock (DERM). This represents 64% of the company’s total 17,194,910 outstanding shares.
The largest institutional shareholders of Journey Medical Corp - Common Stock (DERM) together control 60% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 11% | 1,854,596 | 0% | 0.71% | $14,298,935 |
| WASATCH ADVISORS LP | 7.7% | 1,316,275 | +0.77% | 0.06% | $10,148,480 |
| Opaleye Management Inc. | 5.7% | 975,000 | +0.41% | 1% | $7,517,250 |
| J. Goldman & Co LP | 4.6% | 798,366 | 0.24% | $6,155,402 | |
| VANGUARD GROUP INC | 4.4% | 764,147 | +24% | 0% | $5,891,574 |
| BlackRock, Inc. | 4.2% | 719,784 | +14% | 0% | $5,549,535 |
| MILLENNIUM MANAGEMENT LLC | 2.7% | 457,812 | 0% | $3,529,731 | |
| Pale Fire Capital SE | 2.6% | 444,642 | +95% | 0.44% | $3,428,190 |
| Summit Financial, LLC | 2.3% | 390,419 | +2.8% | 0.04% | $3,010,130 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 2% | 345,977 | -2.3% | 0.41% | $2,667,483 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 313,970 | +13% | 0% | $2,420,885 |
| UBS Group AG | 1.7% | 290,226 | +100% | 0% | $2,237,642 |
| Ikarian Capital, LLC | 1.5% | 251,436 | 0.25% | $1,938,572 | |
| RENAISSANCE TECHNOLOGIES LLC | 1.4% | 244,000 | -1.6% | 0% | $1,881,240 |
| AMERICAN FINANCIAL GROUP INC | 1% | 180,000 | 0% | 0.5% | $1,387,800 |
| STATE STREET CORP | 1% | 173,337 | +19% | 0% | $1,336,428 |
| Legato Capital Management LLC | 0.65% | 111,695 | +9.6% | 0.07% | $861,168 |
| SEI INVESTMENTS CO | 0.64% | 109,351 | 0% | $843,096 | |
| NORTHERN TRUST CORP | 0.54% | 93,669 | +1% | 0% | $722,188 |
| Informed Momentum Co LLC | 0.52% | 89,389 | 0% | 0.08% | $689,189 |
| CITADEL ADVISORS LLC | 0.4% | 69,415 | +382% | 0% | $535,189 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.39% | 67,442 | 0.01% | $519,978 | |
| Geneos Wealth Management Inc. | 0.37% | 63,280 | 0% | 0.01% | $487,889 |
| LAZARD ASSET MANAGEMENT LLC | 0.36% | 62,525 | 0% | $482,068 | |
| Diametric Capital, LP | 0.3% | 51,683 | 0.11% | $398,475 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 11,022,797 | $84,985,269 | +$18,818,454 | $7.71 | 76 |
| 2025 Q3 | 8,692,790 | $61,930,042 | +$15,659,236 | $7.12 | 67 |
| 2025 Q2 | 6,494,302 | $46,629,314 | +$11,145,137 | $7.18 | 56 |
| 2025 Q1 | 5,017,760 | $29,603,817 | +$7,390,927 | $5.90 | 38 |
| 2024 Q4 | 3,813,405 | $14,909,751 | +$6,149,987 | $3.91 | 38 |
| 2024 Q3 | 2,156,982 | $12,186,357 | -$1,194,242 | $5.65 | 36 |
| 2024 Q2 | 2,360,259 | $13,310,203 | +$3,384,583 | $5.64 | 35 |
| 2024 Q1 | 1,816,385 | $6,678,973 | +$973,921 | $3.68 | 31 |
| 2023 Q4 | 1,341,390 | $7,982,763 | -$492,957 | $5.76 | 34 |
| 2023 Q3 | 2,135,266 | $5,850,655 | +$1,401,524 | $2.74 | 20 |
| 2023 Q2 | 1,652,825 | $2,627,537 | -$24,753 | $1.59 | 19 |
| 2023 Q1 | 1,668,350 | $2,620,320 | -$179,207 | $1.57 | 16 |
| 2022 Q4 | 2,672,478 | $5,131,893 | -$313,986 | $1.92 | 18 |
| 2022 Q3 | 1,878,524 | $4,621,000 | +$328,580 | $2.46 | 18 |
| 2022 Q2 | 1,759,431 | $6,580,100 | +$289,703 | $3.74 | 12 |
| 2022 Q1 | 1,644,289 | $7,940,000 | +$35,914 | $4.83 | 13 |
| 2021 Q4 | 1,627,492 | $8,756,000 | +$8,756,000 | $5.38 | 14 |